Verrica Pharmaceuticals Inc (VRCA)

Apr 18, 2025

GLP-1 Receptor Agonist Market Is Booming Worldwide 2025-2032: Verrica Pharmaceuticals, AbbVie Inc. - newstrail.com

Apr 18, 2025

Apr 18, 2025

Leadership Changes at Madrigal Pharmaceuticals Mark New Phase of Growth - MyChesCo

Apr 18, 2025

Apr 13, 2025

Verrica Pharmaceuticals Appoints Dr. Noah Rosenberg as Chief Medical Officer - MSN

Apr 13, 2025

Apr 13, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Earns "Neutral" Rating from HC Wainwright - MarketBeat

Apr 13, 2025

Apr 11, 2025

New Drug Application Submitted in Japan for Verrica Pharmaceuticals’ TO-208 - MSN

Apr 11, 2025

Apr 11, 2025

Needham & Company LLC Reiterates “Hold” Rating for Verrica Pharmaceuticals (NASDAQ:VRCA) - Defense World

Apr 11, 2025

Apr 11, 2025

HC Wainwright Analysts Decrease Earnings Estimates for VRCA - Defense World

Apr 11, 2025

Apr 10, 2025

What is HC Wainwright’s Forecast for VRCA FY2028 Earnings? - Defense World

Apr 10, 2025

Apr 09, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Receives “Neutral” Rating from HC Wainwright - Defense World

Apr 09, 2025

Apr 09, 2025

Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH - MSN

Apr 09, 2025

Apr 09, 2025

H.C. Wainwright maintains Neutral on Verrica stock after Q1 update By Investing.com - Investing.com Canada

Apr 09, 2025

Apr 08, 2025

Verrica Pharmaceuticals at Needham Conference: Strategic Restructuring and Growth By Investing.com - Investing.com Canada

Apr 08, 2025

Apr 07, 2025

In face of U.S. stock market selloff, shares of West Chester firm are on the rise - The Business Journals

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth In Ycanth® In Q1 2025 - marketscreener.com

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025 - The Manila Times

Apr 07, 2025

Apr 07, 2025

Verrica Pharmaceuticals Reports Strong Demand-Led Growth in - GlobeNewswire

Apr 07, 2025

Apr 07, 2025

Record-Breaking Quarter: YCANTH Crosses 10K Units Milestone with 17% Growth - Stock Titan

Apr 07, 2025

Apr 05, 2025

Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors - MSN

Apr 05, 2025

Apr 03, 2025

Here's Why Verrica Pharmaceuticals (VRCA) Is a Great 'Buy the Bottom' Stock Now - MSN

Apr 03, 2025

Apr 03, 2025

Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - The Manila Times

Apr 03, 2025

Apr 03, 2025

Verrica Pharmaceuticals appoints new board member - Investing.com Australia

Apr 03, 2025

Apr 02, 2025

Verrica Pharmaceuticals appoints new board member By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 02, 2025

Palvella Therapeutics Announces Late-Breaking Presentation at Global Pediatric Dermatology Congress - MyChesCo

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals expands board with new director By Investing.com - Investing.com Canada

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals Appoints Dr. Corcoran as Director - TipRanks

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals expands board with new director - Investing.com

Apr 02, 2025

Apr 02, 2025

Strategic Move: Verrica Adds Formation Bio CDO to Board Amid YCANTH Success - Stock Titan

Apr 02, 2025

Apr 02, 2025

Verrica Pharmaceuticals to Present at Needham Healthcare Conference - MSN

Apr 02, 2025

Apr 02, 2025

Palvella Therapeutics Reports 2024 Financial Results and Advances Rare Disease Pipeline - MyChesCo

Apr 02, 2025

Apr 01, 2025

Harmony, Lungpacer, Verrica and Arbutus make C-suite hires - The Business Journals

Apr 01, 2025

Mar 31, 2025

Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire

Mar 31, 2025

Mar 31, 2025

Exclusive: Verrica Pharmaceuticals CEO Fireside Chat at Major Healthcare Conference - Stock Titan

Mar 31, 2025

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Verrica Pharmaceuticals appoints Rosenberg as CMO - MSN

Mar 26, 2025

Mar 26, 2025

Verrica Pharmaceuticals appoints new CMO to advance skin treatments - Investing.com

Mar 26, 2025

Mar 26, 2025

Dermatology Drug Pioneer Joins Verrica to Accelerate YCANTH Growth - Stock Titan

Mar 26, 2025

Mar 25, 2025

VRCA stock plunges to 52-week low, touches $0.5 - Investing.com

Mar 25, 2025

Mar 19, 2025

Verrica Pharmaceuticals Inc (VRCA)’s stock price range in the last year - US Post News

Mar 19, 2025

Mar 18, 2025

Verrica Pharmaceuticals Reports Positive Q4 2024 Results - TipRanks

Mar 18, 2025

Mar 18, 2025

Verrica Pharmaceuticals’ chief legal officer sells shares for $2,804 By Investing.com - Investing.com South Africa

Mar 18, 2025